Results 181 to 190 of about 183,054 (259)
Measurement of glycolysis with heavy water labeling. [PDF]
Ziari N, Hellerstein MK.
europepmc +1 more source
Investigations of Yeast l-Lactate Dehydrogenase (Cytochrome b2)
Keitaro Hiromi, Julian M. Sturtevant
openaire +1 more source
Inherited metabolic epilepsies–established diseases, new approaches
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley +1 more source
Comparative analysis of heterologous lactate dehydrogenase expression in Ogataea polymorpha for enhanced L-Lactic acid production. [PDF]
Tsaruk A +4 more
europepmc +1 more source
Investigations of Yeast L-Lactate Dehydrogenase (Cytochrome b2)
J M Sturtevant, T Y Tsong
openaire +1 more source
Abstract Objectives ES‐481 is a novel potent and selective antagonist of TARP‐y8‐dependent AMPA receptors. We aimed to assess the potential efficacy, safety and tolerability, and pharmacokinetics of different doses of ES‐481 as an add‐on anti‐seizure medication (ASM) in adults with drug‐resistant epilepsy (DRE). Methods This was a Phase 2A double‐blind,
Emma C. Foster +16 more
wiley +1 more source
<i>Bacillus velezensis</i> LUB-8 bioaugmentation: a strategy for lactic acid reduction in pit mud of Chinese <i>nong-xiang baijiu</i>. [PDF]
He G +6 more
europepmc +1 more source
Abstract Background Racehorses undergo profound physiological changes with training and competition, but current biomarkers inadequately capture the complex molecular dynamics of exercise. This study aimed to identify novel plasma biomarkers of training adaptation and peak load using high‐throughput proteomics.
Jowita Grzędzicka +4 more
wiley +1 more source
Association between dynamic serum lactate dehydrogenase levels and functional outcome after endovascular therapy for acute ischemic stroke: A retrospective cohort study. [PDF]
Zhu R, Ma S, Gao W, She J.
europepmc +1 more source
Abstract Background Treatment with the sodium‐glucose co‐transporter 2 (SGLT2) inhibitor canagliflozin in insulin dysregulated (ID) horses has shown promising results in randomised clinical trials. Larger field studies are needed to further evaluate treatment responses and potential adverse effects under real‐world conditions.
Moa Hällbom +3 more
wiley +1 more source

